MarketPeel
Insider Trading Intelligence
ES

Everett Rand Sutherland

KRYS
DIRECTOR · KRYSTAL BIOTECH, INC. · CIK 0001852880
FILING MIX · LIFETIME80%/20%
BUYS
8
SELLS
2
TOTAL VALUE
$32.2K
COMPANIES
2
ACTIVE SINCE
Jan 2022
HOLDINGS NOW
75,812
AVG SELL PX
$7.69
TRADE KIND
SHOWING 10 / 10
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 3 pending
Forward-return performance of every backtestable P/S trade by Everett Rand Sutherland, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%-12.07%-2.04%-10.03%-10.03%
14d1+100.00%-8.64%-5.54%-3.10%-3.10%
30d1+0.00%+2.81%+4.62%-1.81%-1.81%
60d1+100.00%-9.47%+10.95%-20.42%-20.42%
90d1+100.00%-34.81%+10.87%-45.68%-45.68%
180d1(1 pending)
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
KRYS · 5,000 shares · as of Jun 30, 2025
03,4006,80010,20013,600202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 8 buys / 2 sellsCOVERAGE · 18 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
UPB
UPSTREAM BIO, INC.
SALE
Chief Executive Officer
2,095$6.10$12.8K70,812Jun 16, 2026Jun 17, 2026View →
UPB
UPSTREAM BIO, INC.
SALE
Chief Executive Officer
2,093$9.29$19.4K72,907Mar 16, 2026Mar 17, 2026View →
UPB
UPSTREAM BIO, INC.
PURCHASEGRANT
Stock grant
75,00075,000Jan 2, 2026Jan 6, 2026View →
UPB
UPSTREAM BIO, INC.
PURCHASEGRANT
Stock grant
225,000225,000Jan 2, 2026Jan 6, 2026View →
KRYS
KRYSTAL BIOTECH, INC.
PURCHASEGRANT
Stock grant
5,0005,000Jun 30, 2025Jun 30, 2025View →
UPB
UPSTREAM BIO, INC.
PURCHASEGRANT
Stock grant
500,000500,000Feb 6, 2025Feb 7, 2025View →
KRYS
KRYSTAL BIOTECH, INC.
PURCHASEGRANT
Stock grant
5,0005,000Jun 30, 2024Jul 1, 2024View →
KRYS
KRYSTAL BIOTECH, INC.
PURCHASEGRANT
Stock grant
6,8006,800Jun 30, 2023Jul 3, 2023View →
KRYS
KRYSTAL BIOTECH, INC.
PURCHASEGRANT
Stock grant
6,8006,800Jun 30, 2022Jul 1, 2022View →
KRYS
KRYSTAL BIOTECH, INC.
PURCHASEGRANT
Stock grant
13,60013,600Jan 31, 2022Jan 31, 2022View →
Other insiders · KRYS
Loading peer insiders…
About this filer
CIK 0001852880
ROLE
Director
PRIMARY
KRYS
COMPANIES
2
ACTIVE SINCE
Jan 2022
MARKETPEEL · /INSIDER/0001852880DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback